Back to 
WELLS FARGO & COMPANY/MN
WELLS FARGO & COMPANY/MN
EIGRShowing 0 of 19 quarters
Position history for WELLS FARGO & COMPANY/MN's holdings in EIGER BIOPHARMACEUTICALS INC
As of its Q4 2023 13F, Wells Fargo held 307 shares of EIGR (Eiger Biopharmaceuticals), worth $69. Wells Fargo's 13F filings listed EIGR from Q3 2019 to Q4 2023, 18 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EIGR: AMERIPRISE FINANCIAL INC